Zentalis Pharmaceuticals logo

Zentalis Pharmaceuticals share price today

(ZNTL)

Zentalis Pharmaceuticals share price is $3.22 & ₹274.34 as on 25 Dec 2024, 2.30 'hrs' IST

$3.22

0.04

(1.26%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Zentalis Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Zentalis Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Zentalis Pharmaceuticals. Get details on the Indian mutual funds that are investing in Zentalis Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Zentalis Pharmaceuticals's financials.

Zentalis Pharmaceuticals share price movements

  • Today's Low: $3.14
    Today's High: $3.26

    Day's Volatility :3.68%

  • 52 Weeks Low: $2.66
    52 Weeks High: $18.07

    52 Weeks Volatility :85.28%

Zentalis Pharmaceuticals Returns

PeriodZentalis Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
-12.74%
-9.0%
0.0%
6 Months
-23.33%
-4.6%
0.0%
1 Year
-78.98%
3.0%
0.0%
3 Years
-96.06%
0.0%
-21.1%

Zentalis Pharmaceuticals Key Statistics

in dollars & INR

Previous Close
$3.18
Open
$3.21
Today's High
$3.26
Today's Low
$3.14
Market Capitalization
$229.5M
Today's Volume
$420.6K
52 Week High
$18.07
52 Week Low
$2.66
Revenue TTM
$40.6M
EBITDA
$-208.0M
Earnings Per Share (EPS)
$-2.5
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-42.89%

How to invest in Zentalis Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Zentalis Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Zentalis Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Zentalis Pharmaceuticals or ZNTL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Zentalis Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Zentalis Pharmaceuticals shares which would translate to 0.265 fractional shares of Zentalis Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Zentalis Pharmaceuticals, in just a few clicks!

Returns in Zentalis Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Zentalis Pharmaceuticals investment value today

Current value as on today

₹23,257

Returns

₹76,743

(-76.74%)

Returns from Zentalis Pharmaceuticals Stock

₹78,982 (-78.98%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Zentalis Pharmaceuticals

19%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Zentalis Pharmaceuticals on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 19% more investors are searching Zentalis Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Zentalis Pharmaceuticals

  • Matrix Capital Management Company, LLC

    19.59%

  • Eventide Asset Management, LLC

    11.99%

  • FMR Inc

    7.12%

  • BlackRock Inc

    6.76%

  • Vanguard Group Inc

    6.47%

  • Decheng Capital LLC

    4.36%

Analyst Recommendation on Zentalis Pharmaceuticals

Buy

    82%Buy

    17%Hold

    0%Sell

Based on 17 Wall street analysts offering stock ratings for Zentalis Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 17 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
14
14
14
Hold
3
3
3
Sell
0
0
0

Analyst Forecast on Zentalis Pharmaceuticals

What analysts predicted

Upside of 195.03%

Current:

$3.22

Target:

$9.50

Insights on Zentalis Pharmaceuticals

  • Price Movement

    In the last 7 days, ZNTL stock has moved up by 9.9%
  • ZNTL vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 106.2%
  • ZNTL vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 121.4%
  • Price to Sales

    ForZNTL every $1 of sales, investors are willing to pay $5.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Zentalis Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Zentalis Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Zentalis Pharmaceuticals Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Zentalis Pharmaceuticals Inc
-7.47%
-23.33%
-78.98%
-96.06%
-86.12%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.01%
-18.29%
12.56%
91.19%
Biontech Se
-3.72%
41.99%
6.11%
-55.22%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
-1.52%
23.75%
50.98%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-13.61%
0.03%
83.58%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Zentalis Pharmaceuticals Inc
NA
NA
NA
-2.38
-0.43
-0.25
NA
4.98
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Zentalis Pharmaceuticals Inc
Buy
$229.5M
-86.12%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Zentalis Pharmaceuticals

developing potentially best-in-class, novel small molecules targeting fundamental biological pathways in cancer
Organization
Zentalis Pharmaceuticals
Employees
124
CEO
Ms. Andrea Paul J.D.
Industry
Health Technology

Management People of Zentalis Pharmaceuticals

NameTitle
Ms. Andrea Paul J.D.
Chief Legal Officer & Corporate Secretary
Ms. Julie M. Eastland M.B.A.
CEO, President & Director
Mr. Vincent Vultaggio
VP of Finance & Interim Principal Accounting Officer
Dr. Mark Lackner Ph.D.
Chief Scientific Officer

Important FAQs about investing in Zentalis Pharmaceuticals from India :

What is Zentalis Pharmaceuticals share price today?

Zentalis Pharmaceuticals share price today stands at $3.22, Open: $3.21 ; Previous Close: $3.18 ; High: $3.26 ; Low: $3.14 ; 52 Week High: $18.07 ; 52 Week Low: $2.66. The stock opens at $3.21, after a previous close of $3.18. The stock reached a daily high of $3.26 and a low of $3.14, with a 52-week high of $18.07 and a 52-week low of $2.66.

Can Indians buy Zentalis Pharmaceuticals shares?

Yes, Indians can invest in the Zentalis Pharmaceuticals (ZNTL) from India.

With INDmoney, you can buy Zentalis Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Zentalis Pharmaceuticals at zero transaction cost.

How can I buy Zentalis Pharmaceuticals shares from India?

It is very easy to buy Zentalis Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Zentalis Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Zentalis Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Zentalis Pharmaceuticals stocks?

To start investing in Zentalis Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Zentalis Pharmaceuticals

Today’s highest price of Zentalis Pharmaceuticals (ZNTL) is $3.26.

Today’s lowest price of Zentalis Pharmaceuticals (ZNTL) is $3.14.

What is today's market capitalisation of Zentalis Pharmaceuticals

Today's market capitalisation of Zentalis Pharmaceuticals ZNTL is 229.5M

What is the 52 Week High and Low Range of Zentalis Pharmaceuticals

  • 52 Week High

    $18.07

  • 52 Week Low

    $2.66

What are the historical returns of Zentalis Pharmaceuticals?

  • 1 Month Returns

    -7.47%

  • 3 Months Returns

    -23.33%

  • 1 Year Returns

    -78.98%

  • 5 Years Returns

    -86.12%

Who is the Chief Executive Officer (CEO) of Zentalis Pharmaceuticals

Ms. Andrea Paul J.D. is the current Chief Executive Officer (CEO) of Zentalis Pharmaceuticals.